Message from the CEO

Currently, the pharmaceutical industry is experiencing an average annual growth of 7%, driven by the return of patients to hospital treatments

and the increasing global trend toward health and wellness. In 2024, Thailand officially enters a fully aged society, resulting in a continuous expansion of demand for medicines within the healthcare system.

Therefore, in 2024, the company is focusing on sustainability to promote better health for the Thai population, aligned with the company’s vision: “To be a leader in innovation, operate with good governance, integrate Thai wisdom, and deliver value to consumers.”

In 2024, the Board of Directors approved the Net Zero goal as the highest environmental objective for the group. The company also supports activities that foster strong societal relationships and enhance employee development through job-specific training. Moreover, the company remains committed to monitoring and managing risks, while promoting transparency and fairness among executives and employees. This ensures adherence to good corporate governance principles for listed companies and emphasizes ethical, transparent, and auditable operations, fostering the company’s path toward sustainable growth.

Next year, the group intends to continue researching and developing new products and innovations to meet the growing health market demand and consumer needs. It will push forward the development of new generic medicines annually and incorporate consumer feedback into business operations. The group aims to ensure that consumers have access to high-quality medicines at reasonable prices, promoting improved health for all Thais.

Pharmacist Suvit Ngampoopun
Chief Executive Officer
Bangkok Lab and Cosmetic Public Company Limited